SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
FDA Calendar Updates: MELA, PGNX, VPHM, WYE
PGNX
|
|
|
-29.24%
in
109 days
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 288 entries as of 8/5/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, ANDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage cli>...
|
FDA Calendar Updates: MITI, KERX, GSK, DYAX, ARNA, PGNX
PGNX
|
|
|
+5.99%
in
58 days
(closed on 08/05/09)
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of about 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-s>...
|
From the Blogosphere
A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
On Wednesday (Nov. 18), Progenic's Pharmaceutical (PGNX), received some good news in the form of a Reuters story stating that the widely-used painkiller drug, morphine, may actually accelerate cancer growth in patients. Researchers in the US have results from two studies that show that morphine could be on the wrong side of the fight against cancer. But PGNX's drug, Relistor, has shown promise in reversing some of the tumor-generating effects in mice and, significantly, in lung cancer cells. <>The article also quoted Patrick SIngleton of the University of Chicago Medical Center, who remarked o>...
|
Analyst downgrades: Concur Tech, Groupe Danone, General Motors
Monday's Upgrades and Downgrades
|
|
|
<> Upgrades Wright Medical (WMGI)- Leerink Swann Mkt Perform » Outperform Axsys Technologies (AXYS)- Boenning & Scattergood Market Perform » Market Outperform Trimble Navigation (TRMB)- Piper Jaffray Neutral » Buy Emulex (ELX)- Morgan Keegan Mkt Perform » Outperform Synovus (SNV)- Bernstein Mkt Perform » Outperform Health Management (HMA)- Credit Suisse Neutral » Outperform Tenet Healthcare (THC)- Credit Suisse Neutral » Outperform Northrop Grumman (NOC)- Cowen & Co Neutral » Outperform Sohu.com (SOHU)- Citigroup Hold » Buy Progenics Pharm (PGNX)- Ci>...
|
Monday's Upgrades and Downgrades
|
<> Upgrades Wright Medical (WMGI)- Leerink Swann Mkt Perform » Outperform Axsys Technologies (AXYS)- Boenning & Scattergood Market Perform » Market Outperform Trimble Navigation (TRMB)- Piper Jaffray Neutral » Buy Emulex (ELX)- Morgan Keegan Mkt Perform » Outperform Synovus (SNV)- Bernstein Mkt Perform » Outperform Health Management (HMA)- Credit Suisse Neutral » Outperform Tenet Healthcare (THC)- Credit Suisse Neutral » Outperform Northrop Grumman (NOC)- Cowen & Co Neutral » Outperform Sohu.com (SOHU)- Citigroup Hold » Buy Progenics Pharm (PGNX)- Ci>...
|
Pre-Open Movers 2/25:Progenics Pharma (PGNX) Jumps On FDA Approval, Netgear (NTGR) Down on Results
|
<>StreetInsider.com Pre-Open Movers:
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) 23% HIGHER; Progenics and Wyeth (NYSE: WYE) announced that the FDA has approved RELISTOR subcutaneous injection for the treatment of opioid-induced constipation in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient.
ISIS Pharmaceuticals Inc. (Nasdaq: ISIS) 23% LOWER; The FDA has provided guidance regarding approval requirements for mipomersen. The FDA has indicated that reduction of LDL-cholesterol is an acceptable surrogate endpoint for >...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on PGNX |
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|